Mechanism of Action and Pharmacology
The action of Celecoxibum is based on the selective inhibition of cyclooxygenase-2 (COX-2) activity. This targeted approach fundamentally distinguishes this drug from non-selective NSAIDs.
A pharmacokinetic feature of the drug is that its pharmacological effect develops relatively slowly.
Key Benefits of Selectivity
Due to its selective effect on COX-2, this agent offers important clinical advantages:
- Maintains the core therapeutic properties of nonsteroidal anti-inflammatory drugs.
- Provides gastroprotection: the gastric mucosa is spared from direct ulcerogenic damage.
- Has no effect on platelet aggregation pathways.
- Preserves normal renal blood flow.
Indications for Use
In clinical practice, the drug is prescribed for patients with musculoskeletal disorders. The primary indications include:
- Osteoarthritis.
- Rheumatoid arthritis.
Adverse Reactions and Risks
Various adverse reactions may occur during therapy. Common manifestations include:
- Abdominal pain.
- Diarrhea.
- Allergic reactions.
Particular attention is paid to specific cardiovascular effects. This drug can cause class-specific complications, including elevated blood pressure, as well as an increased risk of myocardial infarction, stroke, and serious thromboembolic events.